Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus (2019-nCoV)

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus (2019-nCoV)

Published Date:

January 17, 2020

Series:

2019 novel coronavirus, Wuhan, China

Up-to-Date Info:

To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Language:

English

[PDF-59.22 KB]

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Description:

To date, we do not fully understand the pathogenic potential and transmission dynamics of 2019 Novel Coronavirus (2019-nCoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that may contain 2019-nCoV. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible 2019-nCoV infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling 2019-nCoV specimens are provided below.

Subject:

[+]

Document Type:

Webpage

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

lab-biosafety-guidelines.html

text/html

You May Also Like:

Frequently asked questions about biosafety and COVID-19

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

June 5, 2020

Series:

Coronavirus Disease 2019 (CoVID-19)

Description:

Updated June 5, 2020

File Type:

[PDF - 180.07 KB]
Laboratory biosafety and COVID-19 : questions and answers

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

March 19, 2020

Series:

Coronavirus Disease 2019 (CoVID-19)

Description:

Updated March 19, 2020

File Type:

[PDF - 144.56 KB]
Frequently asked questions about biosafety and COVID-19

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

May 11, 2020

Series:

Coronavirus Disease 2019 (CoVID-19)

Description:

Updated May 11, 2020

File Type:

[PDF - 145.33 KB]
Frequently asked questions about laboratory biosafety and SARS-CoV-2

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

March 20, 2020

Series:

Coronavirus Disease 2019 (CoVID-19)

Description:

Specimen Handling -- Specimen Packing and Shipping.

File Type:

[PDF - 130.16 KB]
Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

Aug. 11, 2020

Series:

Coronavirus Disease 2019 (CoVID-19)

Description:

Updated Aug. 11, 2020Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the r...

File Type:

[PDF - 210.12 KB]